{"id":"W3033287571","doi":"10.1016/j.jcf.2020.05.011","title":"Building global development strategies for cf therapeutics during a transitional cftr modulator era","year":2020,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Medical Research Council; South Carolina Clinical and Translational Research Institute, Medical University of South Carolina; National Institutes of Health; Queen's University; National Health and Medical Research Council; Queen's University Belfast; European Commission; Gilead Sciences; Cystic Fibrosis Canada; Children's Hospital Foundation; National Institute for Health and Care Research; Medical University of South Carolina; U.S. Food and Drug Administration; University of South Carolina; Chiesi Farmaceutici; Novartis; Michael Smith Health Research BC; Cystic Fibrosis Foundation","keywords":"Medicine; Harmonization; Drug development; Cystic fibrosis; Globe; Process (computing); Intensive care medicine; Pharmacology; Computer science; Drug; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004165205,0.0006144712,0.002737796,0.0003037156,0.0001864334,0.00019097,0.0004089904,0.0002936483,0.00005582346],"category_scores_gemma":[0.000321886,0.0004666263,0.001251172,0.0005347244,0.0001189352,0.0002953038,0.00006695849,0.0007803871,0.00001193033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001200238,"about_ca_system_score_gemma":0.00515617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001428705,"about_ca_topic_score_gemma":9.864792e-7,"domain_scores_codex":[0.9957035,0.0001175894,0.001868337,0.0004117578,0.001291188,0.0006075997],"domain_scores_gemma":[0.9970907,0.0006293872,0.0009758332,0.0002408397,0.0005716187,0.0004916308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001640375,0.000192813,0.000003920934,0.05886331,0.002531441,0.0002623359,0.0001465481,0.000133082,0.00124896,0.0005249301,0.0002571139,0.9341952],"study_design_scores_gemma":[0.001965228,0.0009673762,0.000247042,0.03537699,0.002878998,0.002666142,0.00009851169,0.00010099,0.0001128573,0.001053489,0.9540442,0.0004881684],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003438093,0.9270685,0.07065918,0.0002148806,0.0003289762,0.001033215,0.0002816077,0.00003515263,0.00003472218],"genre_scores_gemma":[0.000596858,0.5792614,0.4188725,0.00004841376,0.000981488,0.00007545377,0.0000462797,0.00009214255,0.00002544761],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9537871,"threshold_uncertainty_score":0.9997786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04768106510205374,"score_gpt":0.3795932998339098,"score_spread":0.331912234731856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}